News in the Life Sciences Industry

SINGAPORE, June 24, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority has approved Vosevi (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), a once-daily single tablet regimen for the re-treatment of adults with genotype 1-6 chronic... Read more ››

HARLOW, England, June 21, 2019 /PRNewswire/ -- John Weiss & Son, the leading manufacturer and distributor of gold-standard ophthalmic micro-surgical instruments and procedures, is pleased to offer its latest catalogue, now... Read more ››

LONDON, June 20, 2019 /PRNewswire/ --

BELLINGHAM, Wash. and CARDIFF, Wales, June 20, 2019 /PRNewswire/ -- SPIE, the international society for optics and photonics, has... Read more ››

DUBLIN, June 17, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Drug Enforcement Agency (DEA) has designated solriamfetol, also known as Sunosi, as a Schedule IV medicine. With U.S. Food and Drug Administration (FDA) approval on March 20, 2019,... Read more ››